SCHEMBL29566993

SCHEMBL29566993

Cc1ccc(C(=O)O)cc1Oc1cc(-c2c(C)cccc2C)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.37
▸ FGFR1 P11362 3/20 0.37
▸ KDR P35968 3/20 0.37
▸ BRD4 O60885 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PTK2 Q05397 1/20 0.35
▸ HCK P08631 1/20 0.35
▸ NR2C2 P49116 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ WDR5 P61964 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ FABP4 P15090 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309564 1.00 EGFR (0.37) EGFRFGFR1KDRBRD4TSHR
SCHEMBL29566567 0.93 BRD4 (0.38) EGFRFGFR1KDRBRD4TSHR
SCHEMBL24310099 0.93 BRD4 (0.38) EGFRFGFR1KDRBRD4TSHR
SCHEMBL26810170 0.92 EGFR (0.38) EGFRFGFR1KDRBRD4TSHR
SCHEMBL26810167 0.90 HCK (0.38) EGFRFGFR1KDRBRD4HCK
SCHEMBL29566838 0.90 GFER (0.39) EGFRFGFR1KDRTSHRSMN1; SMN2
SCHEMBL24310039 0.90 GFER (0.39) EGFRFGFR1KDRTSHRSMN1; SMN2
SCHEMBL26810173 0.90 BRD4 (0.38) EGFRFGFR1KDRBRD4HCK
SCHEMBL24309566 0.89 HCK (0.37) EGFRFGFR1KDRBRD4SMN1; SMN2
SCHEMBL29567068 0.89 HCK (0.37) EGFRFGFR1KDRBRD4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback